Vontobel Holding
ATNM icon

Vontobel Holding’s Actinium Pharmaceuticals ATNM Stock Holding History

Vontobel Holding’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Buy
50,000
+20,000
+67% +$23.1K ﹤0.01% 1449
2026
Q1 		$29.9K Hold
30,000
– – ﹤0.01% 1181
2025
Q4 		$40.8K Hold
30,000
– – ﹤0.01% 1411
2025
Q3 		$48K Hold
30,000
– – ﹤0.01% 1327
2025
Q2 		$42K Hold
30,000
– – ﹤0.01% 1239
2025
Q1 		$48.3K Buy
30,000
+5,000
+20% +$6.35K ﹤0.01% 1061
2024
Q4 		$31.5K Buy
+25,000
New +$38.8K ﹤0.01% 1085

Other funds holding ATNM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vontobel Holding's ATNM Position: Q2 2026 in Review

Vontobel Holding increased its Actinium Pharmaceuticals (ATNM) stake by 67% in Q2 2026, buying an estimated $23.1K and bringing the position to 50,000 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

Vontobel Holding first reported a position in ATNM in Q4 2024 and has held it in 7 quarters since. 47 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • Vontobel Holding held 50,000 shares of Actinium Pharmaceuticals worth $49K as of Q2 2026.
  • Vontobel Holding bought 20,000 Actinium Pharmaceuticals shares in Q2 2026, an estimated $23.1K.
  • Actinium Pharmaceuticals made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1449 holding.
  • Vontobel Holding first reported a position in Actinium Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 47 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.